ERBB2 rs2145865647: Understanding This Rare Genetic Variant
The rs2145865647 variant is a rare genetic change located within the ERBB2 gene, which encodes a critical receptor tyrosine kinase involved in cell growth and signaling. Research into this specific variant is ongoing, with current studies focusing on its potential influence on cellular stress response pathways.
What each genotype means
Typical ERBB2 signaling
This is the most common genotype, representing the standard sequence for the ERBB2 gene in the general population. It is associated with normal cellular stress signaling pathways as defined by current reference standards.
This is the major allele genotype found in the vast majority of the global population.
Variant ERBB2 signaling
This genotype indicates the presence of one copy of the variant allele, which may influence cellular stress signaling pathways. Because this variant is rare, the specific functional consequences for an individual are not fully established, and clinical significance remains under investigation.
This genotype is rare and observed at very low frequencies across most studied ancestral populations.
Variant ERBB2 signaling
This genotype indicates the presence of two copies of the variant allele, which may alter cellular stress signaling compared to the common sequence. Given the rarity of this variant, the exact biological impact is currently uncertain, and it is not used for clinical diagnosis.
This genotype is extremely rare and is not commonly identified in standard population genomic databases.
What is the rs2145865647 Variant?
The rs2145865647 variant is a single nucleotide polymorphism (SNP) situated within the ERBB2 gene, also known as HER2. This gene is located on chromosome 17 and plays a fundamental role in human biology by encoding a transmembrane receptor that helps regulate cell proliferation, differentiation, and survival. When a variant like rs2145865647 occurs, it represents a specific change in the DNA sequence at a precise location. Because this is a missense variant, it may result in the substitution of one amino acid for another in the resulting protein structure. Scientists track these variants to understand how subtle changes in our genetic code might influence the way our cells communicate and respond to environmental or internal stressors. While many variants in the human genome are common, rs2145865647 is classified as rare, meaning it is found in only a very small percentage of the population.
The Role of the ERBB2 Gene
The ERBB2 gene is a member of the epidermal growth factor receptor (EGF) family. It functions as a receptor tyrosine kinase, a type of protein that acts as a switch to turn on various signaling pathways inside the cell. Unlike other members of its family, ERBB2 does not bind directly to growth factors; instead, it acts as a preferred partner for other ERBB receptors, forming heterodimers that amplify signaling cascades. These pathways are essential for normal development and the maintenance of healthy tissues. When these pathways are activated, they influence processes such as microtubule stabilization, transcriptional regulation, and protein synthesis. Because of its central role in controlling cell growth, the ERBB2 gene is a subject of intense study in both developmental biology and oncology, where researchers investigate how its activity—or lack thereof—contributes to cellular health and disease progression.
Research and Evidence Strength
Current evidence regarding the clinical significance of rs2145865647 is considered moderate. While the ERBB2 gene itself is well-characterized in scientific literature, specific data on this particular variant is limited. Research in the field often focuses on how rare germline coding variants in ERBB2 may predispose individuals to certain conditions, such as myeloproliferative neoplasms or other malignancies. However, it is important to distinguish between general gene function and the specific impact of a single variant. Many variants identified in large-scale genomic studies are still being evaluated to determine if they have a functional impact on protein activity or if they are simply neutral markers. Because the evidence for rs2145865647 is not yet definitive, it is categorized as a variant requiring further investigation. Researchers continue to use population-scale databases to correlate this variant with specific health outcomes, but current findings should be viewed as preliminary rather than diagnostic.
Population Frequency and Interpretation
The rs2145865647 variant is rare across global populations. In genomics, a variant is typically considered rare if its frequency is very low, often below 1% in the general population. Because of this rarity, it is difficult to establish strong statistical associations with specific health traits or conditions, as there are fewer individuals carrying the variant to study. When interpreting information about rare variants, it is essential to remember that genetic data is probabilistic, not deterministic. Having a rare variant does not automatically imply a specific health outcome. Instead, it suggests that the variant is a unique feature of an individual's genetic profile. As more people participate in genomic research, our understanding of these rare variants will improve, providing a clearer picture of how they are distributed across different ancestral backgrounds and what they might mean for individual health.
What You Can Do With This Information
If you have received information about your status for the rs2145865647 variant, it is important to approach it with a balanced perspective. This information is educational and is not a medical diagnosis. Because the clinical significance of this variant is still being researched, it cannot be used to predict specific health outcomes or guide medical treatment. If you are concerned about your genetic health or have a family history of conditions related to cell signaling or cancer, the best course of action is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your results in the context of your overall health, family history, and lifestyle. Never make changes to your medical care or medication regimen based on genetic data without first discussing it with your clinician or pharmacist, who can provide personalized guidance based on established clinical standards.
How common is this variant?
The rs2145865647 variant is classified as rare, appearing at a very low frequency across diverse human populations.
Frequently asked questions
Is rs2145865647 a disease-causing mutation?
Currently, there is no evidence to classify rs2145865647 as a definitive disease-causing mutation. It is a rare variant, and its clinical significance is still being evaluated by the scientific community.
Should I be worried if I have this variant?
Genetic variants are common, and most do not have a significant impact on health. Because the evidence for this variant is limited, it is not a cause for immediate concern; however, you should discuss any health questions with your doctor.
Can I use this information to change my medication?
No. You should never change your medication or treatment plan based on genetic information without consulting your clinician or pharmacist. They are the only ones who can safely manage your medical care.
Where can I find more information about ERBB2?
You can find reliable information about the ERBB2 gene on resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2145865647?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29